Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Author: Ritu Negi

Science and healthcare content writer with a background in Microbiology, Biotechnology and regulatory affairs. Specialized in Microbiological Testing, pharmaceutical marketing, clinical research trends, NABL/ISO guidelines, Quality control and public health topics. Blending scientific accuracy with clear, reader-friendly insights to support evidence-based decision-making in healthcare.
Specialty Pharmacy Distribution Strategies
Posted in
  • Industry Landscape

Specialty Pharmacy Distribution Strategies

Specialty pharmacy distribution has become the backbone of modern pharmaceutical commercialization. Biologics, gene therapies, and high-cost … Specialty Pharmacy Distribution StrategiesRead more

by Ritu Negi•March 18, 2026March 18, 2026•0
How to Handle Payer Rejections
Posted in
  • Industry Landscape

How to Handle Payer Rejections

Payer rejections whether in the form of prior authorization denials, formulary exclusions, or claim rejections have … How to Handle Payer RejectionsRead more

by Ritu Negi•March 18, 2026March 18, 2026•0
Copay Assistance Programs: Complete Guide
Posted in
  • Industry Landscape

Copay Assistance Programs: Complete Guide

Copay assistance programs have become one of the most influential—and controversial—tools in pharmaceutical access. They sit … Copay Assistance Programs: Complete GuideRead more

by Ritu Negi•March 18, 2026March 18, 2026•0
Understanding Pharmacy Benefit Managers (PBMs)
Posted in
  • Industry Landscape

Understanding Pharmacy Benefit Managers (PBMs)

Pharmacy Benefit Managers (PBMs) sit at the center of the modern pharmaceutical ecosystem. They influence which … Understanding Pharmacy Benefit Managers (PBMs)Read more

by Ritu Negi•March 18, 2026March 18, 2026•0
How to Position Your Drug on Formularies
Posted in
  • Industry Landscape

How to Position Your Drug on Formularies

Formulary positioning has become the single most decisive factor in pharmaceutical market success. In modern healthcare … How to Position Your Drug on FormulariesRead more

by Ritu Negi•March 18, 2026March 18, 2026•0
Health Economics and Outcomes Research (HEOR) for Sales Reps
Posted in
  • Industry Landscape

Health Economics and Outcomes Research (HEOR) for Sales Reps

Health Economics and Outcomes Research (HEOR) has moved from a back-office analytics function to a frontline … Health Economics and Outcomes Research (HEOR) for Sales RepsRead more

by Ritu Negi•March 18, 2026March 18, 2026•0
Step Therapy Protocols: Impact on Pharmaceutical Sales
Posted in
  • Industry Landscape

Step Therapy Protocols: Impact on Pharmaceutical Sales

Step therapy protocols often called “fail-first” requirements sit at the intersection of cost containment, clinical decision-making, … Step Therapy Protocols: Impact on Pharmaceutical SalesRead more

by Ritu Negi•March 18, 2026March 18, 2026•0
How to Navigate Medicare Part D Coverage
Posted in
  • Industry Landscape

How to Navigate Medicare Part D Coverage

Introduction: Why Medicare Part D Matters More Than Ever Prescription drug affordability has become one of … How to Navigate Medicare Part D CoverageRead more

by Ritu Negi•March 18, 2026March 18, 2026•0
Value-Based Contracting in Pharmaceuticals Explained.
Posted in
  • Industry Landscape

Value-Based Contracting in Pharmaceuticals Explained.

Introduction: From Volume to Value The pharmaceutical industry has entered a structural transition. For decades, manufacturers … Value-Based Contracting in Pharmaceuticals Explained.Read more

by Ritu Negi•March 18, 2026March 18, 2026•0
How to Work with Insurance Companies as a Pharma Rep
Posted in
  • Industry Landscape

How to Work with Insurance Companies as a Pharma Rep

Pharmaceutical sales has undergone a structural shift. The physician no longer serves as the sole decision-maker. … How to Work with Insurance Companies as a Pharma RepRead more

by Ritu Negi•March 18, 2026March 18, 2026•0

Posts pagination

1 2 … 22 Next

Recent Posts

  • The Silent Architects: How Private Equity Is Rewriting the Rules of Pharmaceutical Commercialization
  • Location Is the New Targeting: How Geofencing Is Changing Who Gets Diagnosed and Treated
  • When a Drug Loses Its Patent, Marketing Becomes Defense, Not Growth
  • The Hidden Compliance Risk of AI in Pharmaceutical Promotion
  • The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A